Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
192M
-
Number of holders
-
561
-
Total 13F shares, excl. options
-
182M
-
Shares change
-
+89.9K
-
Total reported value, excl. options
-
$18.8B
-
Value change
-
+$42.4M
-
Put/Call ratio
-
0.63
-
Number of buys
-
254
-
Number of sells
-
-234
-
Price
-
$103.49
Significant Holders of BIOMARIN PHARMACEUTICAL INC - COM (BMRN) as of Q4 2022
646 filings reported holding BMRN - BIOMARIN PHARMACEUTICAL INC - COM as of Q4 2022.
BIOMARIN PHARMACEUTICAL INC - COM (BMRN) has 561 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 182M shares
of 192M outstanding shares and own 94.85% of the company stock.
Largest 10 shareholders include PRIMECAP MANAGEMENT CO/CA/ (17.6M shares), VANGUARD GROUP INC (17.4M shares), BlackRock Inc. (14.5M shares), Dodge & Cox (14.4M shares), BAKER BROS. ADVISORS LP (7.62M shares), Capital Research Global Investors (5.65M shares), STATE STREET CORP (5.39M shares), VIKING GLOBAL INVESTORS LP (5.27M shares), AMERIPRISE FINANCIAL INC (4.65M shares), and JANUS HENDERSON GROUP PLC (3.89M shares).
This table shows the top 561 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.